A review of renal GH/IGF1 family gene expression in chronic kidney diseases

Growth Horm IGF Res. 2019 Oct-Dec:48-49:1-4. doi: 10.1016/j.ghir.2019.07.001. Epub 2019 Jul 16.

Abstract

Despite decades of study on the contribution of growth hormone (GH) to the development of kidney disease, there remains the question of the relative contribution of elevated levels of GH to kidney damage in humans, particularly in diabetic nephropathy occurring in type 1 patients. In this study, we reviewed several publicly available datasets to examine transcription of twelve genes associated with the GH/IGF1 axis in several types of human and rodent kidney diseases. Our analyses revealed downregulation of renal GHR and IGF1 gene expression in several different chronic human kidney diseases, including diabetic nephropathy, with general upregulation of IGFBP6 in the same tissues and diseases. These findings were generally supported by a review of studies in rodent models. In healthy and diseased human kidneys, increased GHR gene expression was associated with increases in glomerular filtration rate (GFR) and decreases in serum creatinine. IGFBP6 gene expression demonstrated the opposite clinical correlation. Our results suggest the kidney may exhibit GH insensitivity due to low GHR gene expression during most chronic kidney diseases.

Keywords: Chronic kidney disease; Diabetic nephropathy; GH/IGF1 axis; Growth hormone; Growth hormone receptor; Insulin-like growth factor 1.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Gene Expression Regulation*
  • Human Growth Hormone / metabolism*
  • Humans
  • Insulin-Like Growth Factor I / metabolism*
  • Renal Insufficiency, Chronic / physiopathology*

Substances

  • Human Growth Hormone
  • Insulin-Like Growth Factor I